arrow
M

Marla C. Dubinsky

Mount Sinai Hospital
H指数:83
被引数:3.5万

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Real-world effectiveness and safety of risankizumab induction and maintenance therapy in pediatric patients with Crohn’s disease: a multicenter retrospective analysis

瑞沙利珠单抗在克罗恩病儿科患者中的诱导和维持治疗的真实世界有效性与安全性:一项多中心回顾性分析

2026-09-300
PRE
Risk of serious infection, myocardial infarction, stroke, and thromboembolic events in patients in the United States with ulcerative colitis treated with tofacitinib compared with biologic treatments

与生物制剂治疗相比,美国溃疡性结肠炎患者使用托法替布治疗发生严重感染、心肌梗死、中风和血栓栓塞事件的风险

2026-07-280
OAAI
Pregnancy Outcomes After Maternal or Paternal Exposure to Tofacitinib Across Clinical Programs

Mahadevan, U.; Chaparro, M.; Segovia, M.; Guo, X.; Kulisek, N.; Wu, J.; Vranic, I.; Diehl, A.; Kavanaugh, A.; Dubinsky, M. 母体或父体暴露托法替尼后的妊娠结局:临床研究项目汇总. Am. J. Gastroenterol. 2026, 121, 549–553. [Google Scholar] [CrossRef]

2026-02-011
PRE
Efficacy and Safety of Obefazimod in Patients With Moderately to Severely Active Ulcerative Colitis: Results From Two, Phase 3, Randomised, Double-Blind, Placebo-Controlled, 8-Week Induction Trials (ABTECT-1 and 2)

奥贝非齐莫德在患有中度至重度活动性溃疡性结肠炎患者中的疗效与安全性:来自两项为期8周的诱导治疗期3期、随机、双盲、安慰剂对照试验(ABTECT-1和2)的结果

2025-12-010
PRE
Efficacy and Safety with Upadacitinib by Baseline Corticosteroid Use in Patients with Moderately to Severely Active Crohn's Disease

在基线使用皮质类固醇的中度至重度活动性克罗恩病患者中,乌帕替尼的疗效与安全性。

2025-11-011
OAAI
Both Low (TECH) and High (TEAM) Touch Interventions Improve Behavioral Health, IBD Symptoms, and Quality of Life: A Randomized Control Trial

低接触(TECH)和高接触(TEAM)干预均能改善行为健康、IBD症状和生活质量:一项随机对照试验

2025-10-010
PRE
Disease duration impacts intestinal gene expression profiles in Crohn's disease but not in ulcerative colitis

疾病持续时间影响克罗恩病中肠道基因表达谱,但并不影响溃疡性结肠炎。

2025-10-010
PRE
Integrating Intestinal Ultrasound to Clinical Trials in Patients With Crohn's Disease: Opportunities and Challenges

将肠道超声整合到克罗恩病患者的临床试验中:机遇与挑战

2025-09-010
PRE
Long-Term Ozanimod Therapy in Patients With Moderately Active Ulcerative Colitis After Failure of 5-Aminosalicylic Acid

奥扎尼莫德长期治疗对5-氨基水杨酸治疗失败的轻中度溃疡性结肠炎患者的疗效

2025-09-010
OAAI
Global Consensus Statement on the Management of Pregnancy in Inflammatory Bowel Disease

炎症性肠病妊娠管理的全球共识声明

2025-08-015
PRE